Lupin has declared its fourth quarter results. Kamal K Sharma, MD, Lupin says, the company’s endeavour would be to grow around 25% year-on-year (YoY) on organic basis, unless it makes some inorganic moves that could be additive. “Our attempt has always been to improve on EBITDA margins by atleast 75 bps,” he adds.
first published: May 12, 2011 04:27 pm
A collection of the most-viewed Moneycontrol videos.
Live: Will Nifty extend gains to third day and reclaim record highs? | Opening Bell
Decoding Small-Caps - Opportunities, Risks, and the Right Way to Invest
Live: Broad-based buying lifts D-Street for 2nd day, Nifty above 26,100 | Closing Bell
In your 20s? Quick hacks to turn your money mess into money moves
